Skip to main content

Table 2 Treatment outcomes 6 months following surgery or chemotherapy

From: Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker

Chemotherapy

 RECIST CR/ PR/ SD/ PD a

0/10/19/14

Surgery

 R0/ others

25/0

 Recurrence yes/ no

0/25

  1. aCR, complete response; PR, partial response; SD, stable disease; PD, progressive disease
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us